Here are three key updates on spine and orthopedic biologics since Oct. 10.
1. Orthofix earned FDA 510(k) clearance for its OsteoCove advance bioactive synthetic graft. The newly launched bone graft is available in putty and strip configurations, according to a news release. OsteoCove has a specialized granule surface topography for bone forming and is made of biphasic ceramic granule comprised of β-tricalcium phosphate and hydroxyapatitecombined with type-I bovine collagen.
2. DiscGenics is partnering with the U.S. Department of Veterans Affairs to conduct research into forming tissue-engineered discs. DiscGenics' proprietary Discogenic cells will be assessed in use with the VA's whole, tissue-engineered endplate-modified disc-like angle ply structure, called eDAPS.
3. Regenerative orthopedic developer Advanced Biologics has merged with orthobiologic firm Isto Biologics. The companies completed the merger in October after working as partner firms since 2020. Both companies are focused on the development and production of bone-graft products.